Vaccines, blood, antisera, toxins and cultures in   India

Exports In 2022, India exported $1.83B in Vaccines, blood, antisera, toxins and cultures, making it the 18th largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 37th most exported product in India. The main destination of Vaccines, blood, antisera, toxins and cultures exports from India are: Germany ($183M), Netherlands ($160M), Australia ($89.2M), Pakistan ($79.4M), and Canada ($69.3M).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of India between 2021 and 2022 were Germany ($176M), Netherlands ($128M), and Australia ($84.6M).

Imports In 2022, India imported $1.22B in Vaccines, blood, antisera, toxins and cultures, becoming the 32nd largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 81st most imported product in India. India imports Vaccines, blood, antisera, toxins and cultures primarily from: United States ($370M), Netherlands ($160M), Switzerland ($131M), Belgium ($101M), and France ($71.6M).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for India between 2021 and 2022 were United States ($105M), Netherlands ($74.4M), and Austria ($14.6M).